{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:21:52Z","timestamp":1744258912027,"version":"3.40.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","award":["23\/46","23\/67"],"award-info":[{"award-number":["23\/46","23\/67"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health and Welfare Sector Education and Training Authority"},{"DOI":"10.13039\/501100024216","name":"College of Health Sciences, University of KwaZulu-Natal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024216","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031746","name":"Science for Africa Foundation","doi-asserted-by":"crossref","award":["Del-22-007"],"award-info":[{"award-number":["Del-22-007"]}],"id":[{"id":"10.13039\/100031746","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-033558"],"award-info":[{"award-number":["INV-033558"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gilead Sciences, Inc.","award":["19275"],"award-info":[{"award-number":["19275"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02705-x","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T06:25:03Z","timestamp":1744093503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic determinants of HIV-1 subtype C Nef-mediated SERINC3 down-regulation"],"prefix":"10.1186","volume":"22","author":[{"given":"Nikeisha","family":"Samlall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarylee","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasreen","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Brockman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zabrina L.","family":"Brumme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thumbi","family":"Ndung\u2019u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaclyn K.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"2705_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01322-19","author":"CZ Buffalo","year":"2019","unstructured":"Buffalo CZ, Iwamoto Y, Hurley JH, Ren X. How HIV Nef proteins hijack membrane traffic to promote infection. J Virol. 2019. https:\/\/doi.org\/10.1128\/JVI.01322-19.","journal-title":"J Virol."},{"issue":"21","key":"2705_CR2","doi-asserted-by":"publisher","first-page":"9836","DOI":"10.1128\/JVI.74.21.9836-9844.2000","volume":"74","author":"AJ Iafrate","year":"2000","unstructured":"Iafrate AJ, Carl S, Bronson S, Stahl-Hennig C, Swigut T, Skowronski J, et al. Disrupting surfaces of Nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo. J Virol. 2000;74(21):9836\u201344.","journal-title":"J Virol"},{"key":"2705_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1742-4690-10-125","volume":"10","author":"RL Watkins","year":"2013","unstructured":"Watkins RL, Zou W, Denton PW, Krisko JF, Foster JL, Garcia JV. In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis. Retrovirology. 2013;10:125.","journal-title":"Retrovirology"},{"issue":"7572","key":"2705_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature15399","volume":"526","author":"A Rosa","year":"2015","unstructured":"Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh SL, et al. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature. 2015;526(7572):212\u20137.","journal-title":"Nature"},{"issue":"7572","key":"2705_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature15400","volume":"526","author":"Y Usami","year":"2015","unstructured":"Usami Y, Wu Y, G\u00f6ttlinger HG. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature. 2015;526(7572):218\u201323.","journal-title":"Nature"},{"issue":"11","key":"2705_CR6","doi-asserted-by":"publisher","first-page":"e00196","DOI":"10.1128\/JVI.00196-18","volume":"92","author":"J Shi","year":"2018","unstructured":"Shi J, Xiong R, Zhou T, Su P, Zhang X, Qiu X, et al. HIV-1 Nef antagonizes SERINC5 restriction by downregulation of SERINC5 via the endosome\/lysosome system. J Virol. 2018;92(11):e00196.","journal-title":"J Virol."},{"key":"2705_CR7","doi-asserted-by":"publisher","first-page":"1548905","DOI":"10.1155\/2017\/1548905","volume":"2017","author":"GV Gonzalez-Enriquez","year":"2017","unstructured":"Gonzalez-Enriquez GV, Escoto-Delgadillo M, Vazquez-Valls E, Torres-Mendoza BM. SERINC as a restriction factor to inhibit viral infectivity and the interaction with HIV. J Immunol Res. 2017;2017:1548905.","journal-title":"J Immunol Res"},{"issue":"23","key":"2705_CR8","doi-asserted-by":"publisher","first-page":"10915","DOI":"10.1128\/JVI.01246-16","volume":"90","author":"B Trautz","year":"2016","unstructured":"Trautz B, Pierini V, Wombacher R, Stolp B, Chase AJ, Pizzato M, et al. The antagonism of HIV-1 Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor. J Virol. 2016;90(23):10915\u201327.","journal-title":"J Virol"},{"issue":"6","key":"2705_CR9","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.celrep.2019.10.007","volume":"29","author":"SW Jin","year":"2019","unstructured":"Jin SW, Alsahafi N, Kuang XT, Swann SA, Toyoda M, G\u00f6ttlinger H, et al. Natural HIV-1 Nef polymorphisms impair SERINC5 downregulation activity. Cell Rep. 2019;29(6):1449-57.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.007.","journal-title":"Cell Rep"},{"issue":"1","key":"2705_CR10","doi-asserted-by":"publisher","first-page":"19416","DOI":"10.1038\/s41598-020-76375-w","volume":"10","author":"M Toyoda","year":"2020","unstructured":"Toyoda M, Kamori D, Tan TS, Goebuchi K, Ohashi J, Carlson J, et al. Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals. Sci Rep. 2020;10(1):19416.","journal-title":"Sci Rep"},{"issue":"3","key":"2705_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/v13030423","volume":"13","author":"Z Kruize","year":"2021","unstructured":"Kruize Z, van Nuenen AC, van Wijk SW, Girigorie AF, van Dort KA, Booiman T, et al. Nef obtained from individuals with HIV-1 vary in their ability to antagonize SERINC3- and SERINC5-mediated HIV-1 restriction. Viruses. 2021;13(3):423.","journal-title":"Viruses"},{"issue":"1","key":"2705_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12977-023-00618-7","volume":"20","author":"D Naicker","year":"2023","unstructured":"Naicker D, Sonela N, Jin SW, Mulaudzi T, Ojwach D, Reddy T, et al. HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity. Retrovirology. 2023;20(1):3.","journal-title":"Retrovirology"},{"issue":"9","key":"2705_CR13","doi-asserted-by":"publisher","first-page":"e1008813","DOI":"10.1371\/journal.ppat.1008813","volume":"16","author":"SW Jin","year":"2020","unstructured":"Jin SW, Mwimanzi FM, Mann JK, Bwana MB, Lee GQ, Brumme CJ, et al. Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5. PLoS Pathog. 2020;16(9):e1008813.","journal-title":"PLoS Pathog"},{"key":"2705_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.virol.2014.08.009","volume":"468\u2013470","author":"JK Mann","year":"2014","unstructured":"Mann JK, Chopera D, Omarjee S, Kuang XT, Le AQ, Anmole G, et al. Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure. Virology. 2014;468\u2013470:214\u201325.","journal-title":"Virology"},{"key":"2705_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.virol.2019.02.011","volume":"531","author":"L Naidoo","year":"2019","unstructured":"Naidoo L, Mzobe Z, Jin SW, Rajkoomar E, Reddy T, Brockman MA, et al. Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes. Virology. 2019;531:192\u2013202.","journal-title":"Virology"},{"issue":"2","key":"2705_CR16","doi-asserted-by":"publisher","first-page":"vez029","DOI":"10.1093\/ve\/vez029","volume":"5","author":"JP Barton","year":"2019","unstructured":"Barton JP, Rajkoomar E, Mann JK, Murakowski DK, Toyoda M, Mahiti M, et al. Modelling and in vitro testing of the HIV-1 Nef fitness landscape. Virus Evol. 2019;5(2):vez029.","journal-title":"Virus Evol."},{"issue":"11","key":"2705_CR17","doi-asserted-by":"publisher","first-page":"e7727","DOI":"10.1371\/journal.pone.0007727","volume":"4","author":"V Novitsky","year":"2009","unstructured":"Novitsky V, Wang R, Margolin L, Baca J, Kebaabetswe L, Rossenkhan R, et al. Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection. PLoS ONE. 2009;4(11):e7727.","journal-title":"PLoS ONE"},{"issue":"5","key":"2705_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/infdis\/jir394","volume":"204","author":"M Radebe","year":"2011","unstructured":"Radebe M, Nair K, Chonco F, Bishop K, Wright JK, van der Stok M, et al. Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection. J Infect Dis. 2011;204(5):768\u201376.","journal-title":"J Infect Dis"},{"issue":"8","key":"2705_CR19","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1128\/JVI.02520-10","volume":"85","author":"JK Wright","year":"2011","unstructured":"Wright JK, Novitsky V, Brockman MA, Brumme ZL, Brumme CJ, Carlson JM, et al. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. J Virol. 2011;85(8):3996\u20134006.","journal-title":"J Virol"},{"issue":"8","key":"2705_CR20","doi-asserted-by":"publisher","first-page":"e71758","DOI":"10.1371\/journal.pone.0071758","volume":"8","author":"DR Chopera","year":"2013","unstructured":"Chopera DR, Mann JK, Mwimanzi P, Omarjee S, Kuang XT, Ndabambi N, et al. No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial. PLoS ONE. 2013;8(8):e71758.","journal-title":"PLoS ONE"},{"key":"2705_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1742-4690-10-100","volume":"10","author":"JK Mann","year":"2013","unstructured":"Mann JK, Byakwaga H, Kuang XT, Le AQ, Brumme CJ, Mwimanzi P, et al. Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes. Retrovirology. 2013;10:100.","journal-title":"Retrovirology"},{"key":"2705_CR22","unstructured":"Brockman and Brumme Lab HIV Research Tools [Internet]. 2023 [cited 10 January 2024]."},{"issue":"16","key":"2705_CR23","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100(16):9440\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2705_CR24","unstructured":"Kutner MH, Nachtsheim CJ, Neter J. Applied Linear Regression Models. 4th Edition, McGraw-Hill\/Irwin, New York. 2004."},{"issue":"10","key":"2705_CR25","doi-asserted-by":"publisher","first-page":"e00137","DOI":"10.1128\/JVI.00137-17","volume":"91","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zhou T, Yang J, Lin Y, Shi J, Zhang X, et al. Identification of SERINC5-001 as the predominant spliced isoform for HIV-1 restriction. J Virol. 2017;91(10):e00137.","journal-title":"J Virol."},{"issue":"1","key":"2705_CR26","doi-asserted-by":"publisher","first-page":"e01398","DOI":"10.1128\/JVI.01398-19","volume":"94","author":"S Ananth","year":"2019","unstructured":"Ananth S, Morath K, Trautz B, Tibroni N, Shytaj IL, Obermaier B, et al. Multifunctional roles of the N-terminal region of HIV-1(SF2)Nef are mediated by three independent protein interaction sites. J Virol. 2019;94(1):e01398.","journal-title":"J Virol."},{"key":"2705_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-10-1","volume":"10","author":"P Mwimanzi","year":"2013","unstructured":"Mwimanzi P, Markle TJ, Martin E, Ogata Y, Kuang XT, Tokunaga M, et al. Attenuation of multiple Nef functions in HIV-1 elite controllers. Retrovirology. 2013;10:1.","journal-title":"Retrovirology"},{"issue":"2","key":"2705_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.24875\/AIDSRev.21000048","volume":"24","author":"A Moyano","year":"2022","unstructured":"Moyano A, Ndung\u2019u T, Mann JK. Determinants of natural HIV-1 control. AIDS Rev. 2022;24(2):51\u20138.","journal-title":"AIDS Rev"},{"issue":"4","key":"2705_CR29","doi-asserted-by":"publisher","first-page":"e02214","DOI":"10.1128\/JVI.02214-16","volume":"91","author":"S Beitari","year":"2017","unstructured":"Beitari S, Ding S, Pan Q, Finzi A, Liang C. Effect of HIV-1 Env on SERINC5 antagonism. J Virol. 2017;91(4):e02214.","journal-title":"J Virol."},{"issue":"24","key":"2705_CR30","doi-asserted-by":"publisher","first-page":"e01221","DOI":"10.1128\/JVI.01221-19","volume":"93","author":"V Passos","year":"2019","unstructured":"Passos V, Zillinger T, Casartelli N, Wachs AS, Xu S, Malassa A, et al. Characterization of endogenous SERINC5 protein as Anti-HIV-1 factor. J Virol. 2019;93(24):e01221.","journal-title":"J Virol."},{"key":"2705_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.virol.2022.12.008","volume":"578","author":"PW Ramirez","year":"2023","unstructured":"Ramirez PW, Vollbrecht T, Acosta FM, Suarez M, Angerstein AO, Wallace J, et al. Nef enhances HIV-1 replication and infectivity independently of SERINC5 in CEM T cells. Virology. 2023;578:154\u201362.","journal-title":"Virology"},{"issue":"3","key":"2705_CR32","doi-asserted-by":"publisher","first-page":"e01071","DOI":"10.1128\/mBio.01071-19","volume":"10","author":"Y Wu","year":"2019","unstructured":"Wu Y, Olety B, Weiss ER, Popova E, Yamanaka H, G\u00f6ttlinger H. Potent enhancement of HIV-1 replication by Nef in the absence of SERINC3 and SERINC5. mBio. 2019;10(3):e01071.","journal-title":"mBio."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02705-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:12:34Z","timestamp":1744218754000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02705-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02705-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (ref: BREC\/00005610\/2023). Written informed consent was obtained from all study participants at the time of recruitment and participant identity remained confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}